Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Octreotide chloride (lipid depot solution)

EU orphan designation number: EU/3/09/645   
Active ingredient: Octreotide chloride (lipid depot solution)
Indication: Treatment of acromegaly
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/06/2009 Centralised Orphan - Designation EMEA/OD/010/09 (2009)4681 of 12/06/2009
30/04/2014 Centralised Orphan - Transfer of orphan designation EMEA/OD/010/09/T/01 (2014)2910 of 28/04/2014
29/08/2014 Centralised Orphan - Change of address